The Hunter Williams Podcast podcast artwork The Hunter Williams Podcast

Peptides and Cancer | 20+ Studies the Critics Won't Show You

30 min

Play episode Listen on the show's site

Sponsors in this episode

No sponsor reads found in this episode's notes.

Host-read ads that the notes don't mention can't be found this way.

Show notes

All links here: ⁠https://hunterwilliamshealth.com/links
Timestamps:
00:00 Intro
01:00 Why I'm making this video
04:00 The plan: peptides with direct anti-cancer evidence
06:02 AOD-9604 and HGH Frag 176-191
07:42 BPC-157
09:54 DSIP (Delta Sleep Inducing Peptide)
11:08 Epitalon
12:30 Follistatin 344
13:30 GHK-Cu
14:36 Kisspeptin
15:58 KPV
17:18 LL-37
18:46 Melanotan 2
19:58 MOTS-c
21:12 Retatrutide
22:34 Semaglutide
23:40 SS-31
24:38 Thymalin
25:26 Thymosin Alpha-1
27:00 Tirzepatide
27:30 VIP (Vasoactive Intestinal Peptide)
28:06 Bottom line and closing thoughts
Description
If you spend any time in the peptide social media world, you've heard it. "Peptides cause cancer." It's the easiest way to scare someone off something, and a lot of people do it without ever showing you a single study.
So I went and pulled the studies. In this video I walk through every peptide on the popular research peptide list that actually has direct anti-cancer evidence in the published literature. Not theory. Not mechanism guesses. Actual studies in cells, animals, and in some cases, humans.
You'll see what the research says about BPC-157, GHK-Cu, Epitalon, KPV, LL-37, Thymosin Alpha-1, MOTS-c, semaglutide, tirzepatide, retatrutide, and a handful more. Some of this evidence is strong. Some is preliminary. I'm honest about both.
This is not medical advice and I'm not telling you peptides cure cancer. That's not what the data says and that's not what I'm claiming. What I am saying is that the next time someone hits you with a 60 second clip telling you peptides cause cancer, you'll have something more substantial to weigh it against.
All study links below.
📚 Studies Referenced (in order of appearance)
AOD-9604 / HGH Frag 176-191
https://pmc.ncbi.nlm.nih.gov/articles/PMC9249349/
BPC-157 https://journals.lww.com/melanomaresearch/citation/2004/08000/bpc_157_inhibits_cell_growth_and_vegf_signalling.50.aspx https://pubmed.ncbi.nlm.nih.gov/29886825/
DSIP
https://pubmed.ncbi.nlm.nih.gov/12782416/
Epitalon
https://pubmed.ncbi.nlm.nih.gov/14501183/ https://pubmed.ncbi.nlm.nih.gov/12209581/ https://pubmed.ncbi.nlm.nih.gov/12049808/
Follistatin 344
https://pmc.ncbi.nlm.nih.gov/articles/PMC9633376/
GHK-Cu
https://neoplasiaresearch.com/index.php/jao/article/view/217 https://www.lidsen.com/journals/genetics/genetics-05-02-128
Kisspeptin
https://pubmed.ncbi.nlm.nih.gov/8944003/ https://pubmed.ncbi.nlm.nih.gov/28944853/
KPV
https://pmc.ncbi.nlm.nih.gov/articles/PMC4957955/
LL-37
https://pmc.ncbi.nlm.nih.gov/articles/PMC3910284/ https://pmc.ncbi.nlm.nih.gov/articles/PMC3659029/
Melanotan 2
https://pmc.ncbi.nlm.nih.gov/articles/PMC7013727/
MOTS-c
https://pmc.ncbi.nlm.nih.gov/articles/PMC11578304/
Retatrutide
https://pmc.ncbi.nlm.nih.gov/articles/PMC11908972/
Semaglutide
https://pmc.ncbi.nlm.nih.gov/articles/PMC11227080/ https://pubmed.ncbi.nlm.nih.gov/38683947/ https://pmc.ncbi.nlm.nih.gov/articles/PMC12587238/
SS-31
https://pmc.ncbi.nlm.nih.gov/articles/PMC7923037/
Thymalin
https://pubmed.ncbi.nlm.nih.gov/6752596/ https://pubmed.ncbi.nlm.nih.gov/29797130/
Thymosin Alpha-1
https://pubmed.ncbi.nlm.nih.gov/8652276/ https://pmc.ncbi.nlm.nih.gov/articles/PMC2748379/ https://pubmed.ncbi.nlm.nih.gov/20194853/ https://pubmed.ncbi.nlm.nih.gov/27900029/ https://pubmed.ncbi.nlm.nih.gov/30063847/
Tirzepatide
https://www.biorxiv.org/content/10.1101/2024.01.20.576484v1 https://aacrjournals.org/cancerres/article/84/6_Supplement/2188/738498/Abstract-2188-Tirzepatide-treatment-restores
VIP
https://pmc.ncbi.nlm.nih.gov/articles/PMC6317926/

From the show's RSS feed.